Does off-pump CABG reduce the composite outcome of death, stroke, myocardial infarction, renal failure, or repeat revascularization in patients undergoing CABG compared to on-pump CABG?
At 5 years of follow-up, off-pump CABG does not significantly differ from on-pump CABG in reducing major adverse cardiovascular and renal events.
In our trial, the rate of the composite outcome of death, stroke, myocardial infarction, renal failure, or repeat revascularization at 5 years of follow-up was similar among patients who underwent off-pump CABG and those who underwent on-pump CABG. (Funded by the Canadian Institutes of Health Research; CORONARY ClinicalTrials.gov number, NCT00463294 .).
Lamy et al. (Sun,) studied this question.